Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge represents Gambro in the sale of Gambro Healthcare
Mandate

Vinge represents Gambro in the sale of Gambro Healthcare

May 10, 2007

Vinge is representing Gambro in the sale of Gambro Healthcare to Bridgepoint. The sale of Gambro Healthcare was a part of the plan that was implemented when Investor and EQT acquired Gambro in June 2006. The sale requires the approval of the EU Commission before it can be concluded.
 
The partner in charge is Fredrik von Baumgarten, who is assisted by associates Tuula Tallavaara, Ulrich Ziche, Marion Ehman and Martin Hall. For financial matters, Gambro is represented by Fabian Ekeblad, together with Ann Bokinge and Hanna Fanning.

Related

Vinge advises Consolid Equity in connection with the establishment of Petra Group

 Vinge has advised Consolid Equity Investment AB ("Consolid Equity") on the acquisition of Ström & Gulliksson, one of the leading patent agencies in the Nordics. The acquisition forms part of the establishment of Petra Group, a European platform aimed at consolidating patent agencies across Europe to combine expertise and resources primarily within patents and trademarks. Consolid acts as a strategic partner in the new group.
July 08, 2026

Vinge has advised Scandic on new credit facilities with SEK 7.5 billion credit facilities

 Vinge has represented Scandic Hotels Group AB (publ) in connection with a facilities agreement for SEK 7,500,000,000 with a syndicate of banks, arranged by DNB Carnegie Investment Bank AB and Nordea Bank Abp, filial i Sverige.
July 08, 2026

Vinge has advised Vitamin Well and its majority shareholders Cinven, Bridgepoint and the founders on Vitamin Well's combination with EMPWR

 Vinge has advised Vitamin Well and its majority shareholders Cinven, the founders of Vitamin Well and Bridgepoint on Vitamin Well's acquisition of EMPWR Nutrition Group from majority seller Waterland Private Equity Investments.
July 03, 2026